Patient Data Reporting Applications & Studies

81. Real-Time, Remote Data Collection For Faster Trial Deployment 7/20/2022

    A leading pharma company was planning a Phase III trial for a SARS-CoV-2 prophylactic therapy and needed to evaluate post-exposure prophylaxis and preemptive treatment in 1,000+ patients at 82 sites. Explore how eSource was rapidly deployed for clinical trial success.

82. Large NCI-Designated Hospital System Trains 400 End Users, Resulting In Increased Levels Of Efficiency And Consistency 6/28/2022

    Learn how an eLearning solution was used to help overburdened trainers from a large National Cancer Institute (NCI)-designated hospital system.

83. Vanderbilt's Advice For Sponsors: How To Make Working With Your EDC Easier For Sites 5/24/2022

    Learn how research sites like Vanderbilt University Medical Center speed study timelines and drive higher quality data entry with a modern EDC.

84. Top 10 Biopharma Achieves Significant Regulatory Efficiency 5/23/2022

    Discover how a top 10 biopharmaceutical company expanded its regulatory efficiency and automated key workflows between their IRB Platform and their electronic master file (eTMF).

85. A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients 5/20/2022

    Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.

86. Implantable Medical Device 11/29/2021

    A leading global medical device company received a warning letter from the United States Food and Drug Administration (FDA), citing a failure to comply with post-approval ePRO (electronic patient-reported outcome assessments) requirements related to a cleared implantable medical device. Find out what happens in the available case study.

87. The Impact Of Mobile App Technology On eCOA 10/27/2021

    Patients are vital to the success of any clinical trial. Yet many trials struggle to keep patients engaged for the duration of the study.

88. Achieving 97% Patient Compliance, Increased Patient Engagement 9/23/2021

    In a proof-of-concept for a decentralized hybrid study, explore how Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population.

89. Accelerating Database Lock: Adaptive Design & Remote Monitoring 8/17/2021

    Reach database lock in less than one month instead of a year. That’s what one large pharmaceutical company achieved by providing real-time remote access to validated clinical data.

90. Using De-Identified Linked Real-World Data To Create An External Control Arm 7/13/2021

    A pharmaceutical company designed its Phase II study of a novel agent to treat metastatic non-small cell lung cancer driven by a rare subtype of EGFR genetic mutation. They needed to construct a control arm that had cohort of patients with the specific subtype of metastatic EGFR non-small cell lung cancer whose disease progressed despite taking platinum-based chemotherapy. By utilizing a platform that allowed them to collect data across three vendors that represented unique patients proved successful and enabled the company to move forwards with the Phase II pivotal trial.